Honz Pharmaceutical Co. Ltd. (300086)
SZSE
6.27
+0.0100 (+0.16%)
Closed
Sep 18, 2026
Day's Range
6.266.45
52 wk Range
5.4615.19
Financial Statements - 300086 - Honz Pharmaceutical Co. Ltd.
Revenue
466.12M▼ 1.4%
Net Income
-234.02M▼ 4.3%Net Margin -50.2%
EBITDA
-129.97M▼ 51.4%
Free Cash Flow
29.12M▲ 238.4%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 466.12M | 472.81M | 739.56M | 535.74M | 836.56M | 921.64M |
| Cost of Goods | 213.47M | 211.08M | 295.77M | 263.60M | 414.46M | 448.80M |
| Gross Profit | 252.64M | 261.73M | 443.79M | 272.13M | 422.10M | 472.83M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -160.04M | -139.09M | 66.49M | -121.40M | 15.22M | 84.78M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | -259.47M | -231.97M | 23.44M | -221.51M | 20.35M | 28.76M |
| Income Tax | -25.44M | -7.54M | 18.27M | -23.56M | 9.78M | 8.77M |
| Net Income | -234.02M | -224.42M | 5.16M | -197.95M | 10.57M | 19.98M |
| EPS Basic | -0.5057 | -0.4737 | 0.0256 | -0.4169 | 0.0244 | 0.0208 |
| EPS Diluted | -0.5057 | -0.4737 | 0.0256 | -0.4169 | 0.0244 | 0.0208 |
| Basic Shares Outstanding | 455.08M | 456.42M | 450.38M | 449.95M | 450.30M | 449M |
| Diluted Shares Outstanding | 455.08M | 456.42M | 450.38M | 449.95M | 450.30M | 449M |
| Ebit | -241.60M | -210.90M | 48.74M | -194.11M | 39.09M | 47.22M |
| Ebitda | -129.97M | -85.83M | 133.53M | -96.05M | 118.50M | 119.37M |
| Net Income Continuous Operations | -234.02M | -224.42M | 5.16M | -197.95M | 10.57M | 19.98M |
| Minority Interests | 3.89M | 8.21M | 6.36M | 10.36M | 416.08K | -10.64M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
